West Pharmaceutical Services, Inc
Medical Supplies
WST
$ 375 (1)%
Share price
$ 28 bn
Market Cap
$ 28 bn
Enterprise Value
Carbon footprint
4.7 Ton
+6.1%
Primary Climate Goal
-1.1%
West Pharmaceutical Services, Inc aims to reduce Scope 1 + 2 by 10% by 2023 from a base year 2018
This target has not been verified as science based according to SBTi
GHG emissions and Carbon intensity
West Pharmaceutical Services, Inc reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 128 Kt (+7.4/+6.1% y-o-y). At the sime time, carbon intensity was down at 45 t (-11 /-19.5% y-o-y).
No public disclosure of Scope 3 emissions has been found for West Pharmaceutical Services, Inc at the moment.
The company is committed to reducing Scope 1 + 2 by 10% by 2023 from a base year 2018, which translates into the estimated reduction of -1.4 Kt per annum over the period of FY2022 - FY2023. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2023 Exerica. All rights reserved.